Shingles (Herpes Zoster) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) - United States, October 2017-June 2018
Early recombinant zoster vaccine safety monitoring findings are consistent with prelicensure clinical trial data. Serious adverse events were rare, and no unexpected patterns were detected. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 31, 2019 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Vaccine Safety Source Type: news

Treating shingles after it appears doesn't reduce increased stroke risk
(American Heart Association) Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 30, 2019 Category: International Medicine & Public Health Source Type: news

Herpes zoster infection
This review covers who is at risk, typical presentation, complications, infectiousness, when to prescribe antivirals and which antiviral, when to refer, use of analgesia, latest vaccine recommendations and the difference between Zostavax and Shingrix. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 16, 2019 Category: Consumer Health News Source Type: news

More Shingles Vaccine On the Way, Maker Says
More doses of Shingrix, the shingles vaccine that has been in very short supply, are on the way to U.S. pharmacies, says drugmaker GlaxoSmithKline. However, demand may still outpace supply. (Source: WebMD Health)
Source: WebMD Health - January 10, 2019 Category: Consumer Health News Source Type: news

Cancer Patients May Face Greater Risk of Shingles
WEDNESDAY, Jan. 9, 2019 -- Newly diagnosed cancer patients may be at increased risk for the painful skin condition shingles, a new study finds. Experts say development of new vaccines might help prevent shingles in cancer patients. The study, of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 9, 2019 Category: General Medicine Source Type: news

Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S. Changing Epidemiology of Herpes Zoster After Vaccine Adoption in the U.S.
Shingles is becoming less common in both adults and children in the U.S., according to results from a database study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 26, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Higher Risk of Shingles Seen in Patients With Certain Cancers
(MedPage Today) -- Vaccine development may help with prevention of herpes zoster in this population (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 14, 2018 Category: Hematology Source Type: news

Cancer patients face higher risk for shingles, new vaccines hold promise for prevention
(Infectious Diseases Society of America) People newly diagnosed with cancer, particularly blood cancers, and those treated with chemotherapy have a greater risk of developing shingles, according to a new study in The Journal of Infectious Diseases. The findings may help guide efforts to prevent the often painful skin condition in cancer patients through the use of new vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 13, 2018 Category: International Medicine & Public Health Source Type: news

‘All I want for Christmas’ is the shingles vaccine, but it’s nearly impossible to find
Shortage of new shingles vaccine worsens as demand soars. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - December 7, 2018 Category: Consumer Health News Authors: Lena H. Sun Source Type: news

Herpes zoster (shingles) immunisation programme 2017 to 2018: evaluation report
This report evaluates the fifth year of the shingles vaccination programme in England from 2017 to 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 30, 2018 Category: Consumer Health News Source Type: news

Chickenpox Outbreak Hits North Carolina School With High Vaccination Exemption Rate
A North Carolina school where a high concentration of families claim religious exemption from vaccines is facing the state’s worst chickenpox outbreak in more than 20 years. The chickenpox outbreak has affected 36 students at Asheville Waldorf School, health officials with Buncombe County said. The outbreak ranks as North Carolina’s largest since a chickenpox vaccine became available more than 20 years ago, the Asheville Citizen Times reports. The Asheville Waldorf School has one of the highest rates in the state of families who opt out of vaccines based on religious beliefs, according to data from North Caroli...
Source: TIME: Health - November 20, 2018 Category: Consumer Health News Authors: Mahita Gajanan Tags: Uncategorized chickenpox North Carolina onetime vaccines Source Type: news

Health Tip: When to Get the Shingles Vaccine
-- Once you have had chickenpox, you are at risk for developing shingles, a painful skin rash and nerve disease that ' s caused by the same virus that causes chickenpox. Shingles can strike at any age, but usually affects adults after age 50, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 19, 2018 Category: General Medicine Source Type: news

Health Tip: When to Get the Shingles Vaccine
Title: Health Tip: When to Get the Shingles VaccineCategory: Health NewsCreated: 11/19/2018 12:00:00 AMLast Editorial Review: 11/19/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - November 19, 2018 Category: Dermatology Source Type: news

Shingles vaccine: Mayo Clinic Radio Health Minute
According to the?Centers for Disease Control and Prevention,?almost 1 out of every 3 people in the U.S. will develop?shingles?in their lifetime. And the risk goes up with age. Vaccines can reduce the risk of shingles, while early treatment can shorten a shingles infection and lessen the chance of complications. In this Mayo Clinic Radio Radio [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 9, 2018 Category: Databases & Libraries Source Type: news

Herpes Zoster Recombinant Vaccine Seems Most Effective
THURSDAY, Nov. 8, 2018 -- The herpes zoster adjuvant recombinant subunit vaccine may be more effective than the live attenuated vaccine, though it is associated with an increased risk for adverse events at the injection site, according to a review... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 8, 2018 Category: Pharmaceuticals Source Type: news